BIO logo

BIO EBITDA

Latest reported$542.10M
BIO Quarterly EBITDA ($25.40M → $542.10M)
High-resolution chart · PNG

BIO ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
542,100,000
-636,600,000
983,800,000
-374,600,000
467,200,000
133,500,000
-847,400,000
912,694,000
-2,737,617,000
540,455,000
477,953,000
186,800,000
-1,452,284,000
132,766,000
1,142,965,000
-161,355,000
-1,175,385,000
-4,330,584,000
-2,003,991,000
5,056,352,000
1,190,838,000
1,330,301,000
1,119,436,000
1,723,789,000
1,286,385,000
937,989,000
708,794,000
-295,991,000
808,642,000
1,166,152,000
-1,000,608,000
391,095,000
380,463,000
903,771,000
85,838,000
79,752,000
44,165,000
58,888,000
9,650,000
66,810,000
70,074,000
59,865,000
94,062,000
64,798,000
76,500,000
67,785,000
90,517,000
70,975,000
90,697,000
57,803,000
93,548,000
66,695,000
95,629,000
68,314,000
106,468,000
99,040,000
110,073,000
90,471,000
118,769,000
98,498,000
99,488,000
93,142,000
106,685,000
98,640,000
95,764,000
91,811,000
56,456,000
91,945,000
85,079,000
73,379,000
37,093,000
75,761,000
81,052,000
75,879,000
54,682,000
52,091,000
50,151,000
53,225,000
44,868,000
43,715,000
56,690,000
60,338,000
38,309,000
39,891,000
42,842,000
55,256,000
45,094,000
39,899,000
46,298,000
47,081,000
44,500,000
44,411,000
46,722,000
54,062,000
43,973,000
45,717,000
41,505,000
44,259,000
45,057,000
31,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.